This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) announced today that it will host a conference call and live audio webcast at 8:30 a.m. EST on Thursday, November 14, 2013 to report its third quarter 2013 financial results and provide a corporate update.
In order to participate in the conference call, please dial 1-866-277-1184 (domestic) or 1-617-597-5360 (international) and provide the access code 66528815. The live webcast can be accessed under “Investor Events” in the Investors section of the Company’s website at
www.iderapharma.com or you may use the link:
A replay of the call will be available at 1:30 p.m. EST on November 14, 2013 until 11:59 p.m. EST on November 20, 2013. To access the replay, please dial 1-888-286-8010 (domestic) or 1-617-801-6888 (international) and reference the access code 73861450. The archived webcast will be available for 30 days in the Investors section of Idera’s website at
About Idera Pharmaceuticals, Inc.
Idera's technology platform involves creating novel synthetic RNA- and DNA-based compounds to modulate immune responses. Idera has applied this platform to develop proprietary Toll-like receptor (TLR) antagonists as immunomodulatory drug candidates. Toll-like receptor antagonists block the overactivation of immune factors which can cause a range of pathological effects. Idera is conducting clinical development of TLR antagonists in autoimmune and inflammatory diseases, and preclinical development of their use in certain genetically defined forms of B-cell lymphoma. More information on Idera is available at iderapharma.com.